American Oncology Network Announces CFO Transition
03 Maio 2024 - 6:30PM
American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC),
a rapidly growing network of community-based oncology practices,
announced today that Dave Gould will step down as Chief Financial
Officer, effective May 17, 2024, to pursue other opportunities. AON
has appointed David Afshar, a seasoned public company executive, to
fulfill the responsibilities of interim Chief Financial Officer,
effective May 20, 2024. AON has initiated a process for a new Chief
Financial Officer.
Afshar is an experienced Chief Financial Officer with strong
financial, operations and administrative experience in
high-performing environments. He has over 25 years of experience in
healthcare services, beginning in public accounting and progressing
to Chief Financial Officer.
Afshar is seasoned in both private equity-backed and public
company environments and has a thorough understanding of key
stakeholder needs, including public and private equity
shareholders, physician shareholders, lenders and rating agencies.
He has served as the Chief Financial Officer at companies from $300
million in revenue to over $1.8 billion. This includes companies
with operations in over 300 locations across the country in
pediatric and adult home healthcare, long-term acute care, and
multi-specialty physician practices.
“I’d like to thank Dave for his contributions to our team and
business over the last several years, where he played a meaningful
role in helping us achieve the important milestone of becoming a
public company. We appreciate his support and wish him the best in
his future endeavors,” said Todd Schonherz, AON Chief Executive
Officer. “Our shared focus at AON remains unchanged: providing
best-in-class cancer care to patients in their local communities.
We remain confident in our strategic plans and the significant
growth opportunities ahead of us, and I look forward to working
closely with David to ensure a smooth transition.”
About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of
physicians and seasoned healthcare leaders partnering to ensure the
long-term success and viability of community oncology and other
specialties. Founded in 2018, AON’s rapidly expanding network
represents more than 240 providers practicing across 21 states. AON
pioneers innovative healthcare solutions through its physician-led
model, fostering value-based care that improves patient outcomes
while reducing costs and expanding access to quality care. AON
equips its network physicians with the tools they need to thrive
independently while providing comprehensive support, integrated
revenue-diversifying ancillary services, and practice management
expertise, enabling physicians to focus on what matters most –
providing the highest standard of care for every patient. AON is
committed to promoting health equity by addressing disparities in
cancer care and ensuring that all patients have access to the care
they need to achieve optimal health outcomes. With a focus on
innovation and collaboration, AON is shaping the future of
community oncology. Learn more at www.AONcology.com.
Investor Contact:Solebury Strategic
CommunicationsInvestors@AONcology.com
American Oncology Network (NASDAQ:AONC)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
American Oncology Network (NASDAQ:AONC)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025